Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site- specific interactions for the DR shared epitope associated with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 40, Issue 7, 1997, Pages 1316-1326

  Penzotti, Julie E ^a   Nepom, Gerald T ^b   Lybrand, Terry P ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HYDROGEN BOND; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MODEL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030885064     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199707)40:7<1316::AID-ART17>3.0.CO;2-I     Document Type: Article

References (61)

1. Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213, 1987
2. Nepom BS, Nepom GT: Immunogenetics and the rheumatic diseases. In, Textbook of Rheumatology. Edited by WN Kelley, ED Harris Jr, S Ruddy, CB Sledge. Philadelphia, WB Saunders, 1993
3. Hiraiwa A, Yamanaka K, Kwok WW, Mickelson EM, Masewicz S, Hansen JA, Radka SF, Nepom GT: Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc Natl Acad Sci U S A 87:8051-8055, 1990
4. Signorelli KL, Watts LM, Lambert LE: The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition. Cell Immunol 162:217-224, 1995
5. Fu XT, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, Sette A, Schwartz BD, Karr RW: Pocket 4 of the HLA-DR (alpha, beta 1*0401) molecule is a major determinant of T cell recognition of peptide. J Exp Med 181:915-926, 1995
6. Hill CM, Liu A, Marshall KW, Mayer J, Jorgensen B, Yuan B, Cubbon RM, Nichols EA, Wicker LS, Rothbard JB: Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J Immunol 152:2890-2898, 1994
7. Penzotti JE, Doherty D, Lybrand TP, Nepom GT: A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J Autoimmun 9:287-293, 1996
8. Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE III, DeBolt S, Ferguson D, Seibel G, Kollman P: AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun 91:1-41, 1995
9. Weiner SJ, Kollman PA, Nguyen DT, Case DA: An all atom force field for simulations of proteins and nucleic acids. J Comp Chem 7:230-252, 1986
10. Ponder JW, Richards FM: Tertiary templates for proteins: use of packing in the enumeration of allowed sequences for different structural classes. J Mol Biol 193:775-791, 1987
11. Gregoret LM, Cohen FE: Novel method for the rapid evaluation of packing in protein structures. J Mol Biol 211:959-974, 1990
12. Mickelson EM, Masewicz S, Smith A, Petersdorf E, Nepom GT, Martin PJ, Hansen JA: T-cell clones identify three distinct epitopes associated with HLA-Dw14. Hum Immunol 32:229-233, 1991
13. Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden BC, Ysern X, Kim JK, Shao X, Ward ES, Mariuzza RA: Crystal structure of the Va domain of a T cell antigen receptor. Science 270:1821-1824, 1995
14. Bentley GA, Boulot G, Karjalainen K, Mariuzza RA: Crystal structure of the β chain of a T cell antigen receptor. Science 267:1984-1987, 1995
15. Tormo J, Stadler E, Skern T, Auer H, Kanzler O, Betzel C, Blaas D, Fita I: Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2. Protein Sci 1:1154-1161, 1992
16. Marquart M, Deisenhofer J, Huber R, Palm W: Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 Å and 1.0 Å resolution. J Mol Biol 141:369-391, 1980
17. Vriend G: WHATIF: a molecular modeling and drug design program. J Mol Graph 8:52-56, 1990
18. Ferrin TE, Huang CC, Jarvis LE, Langridge R: The MIDAS display system. J Mol Graph 6:13-27, 1988
19. Swanson E: PSSHOW: Silicon Graphics 4D Version. Seattle, 1990
20. Chothia C, Boswell DR, Lesk AM: The outline structure of the T cell αβ receptor. EMBO J 7:3745-3755, 1988
21. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221, 1994
22. Connolly ML: Solvent-accessible surfaces of proteins and nucleic acids. Science 221:709-713, 1983
23. Davis MM, Bjorkman PJ: T-cell antigen receptor genes and T-cell recognition. Nature 334:395-402, 1988
24. Claverie JM, Prochnicka-Chalufour A, Bougueleret L: Implications of a Fab-like structure for the T cell receptor. Immunol Today 10:10-14, 1989
25. Almagro JC, Vargas-Madrazo E, Lara-Ochoa F, Horjales E: Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition. Protein Sci 4:1708-1717, 1995
26. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC: Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-141, 1996
27. Epp O, Lattman EE, Schiffer M, Huber R, Palm W: The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-Å resolution. Biochemistry 14:4943-4952, 1975
28. Rini JM, Stanfield RL, Stura EA, Salinas PA, Profy AT, Wilson IA: Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc Natl Acad Sci U S A 90:6325-6329, 1993
29. Stanfield RL, Takimoto-Kamimura M, Rini JM, Profy AT, Wilson IA: Major antigen-induced domain rearrangements in an antibody. Structure 1:83-93, 1993
30. Herron JN, He XM, Mason ML, Voss EW Jr, Edmundson AB: Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol. Proteins 5:271-280, 1989
31. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA: An alpha beta T cell receptor structure at 2.5 angstrom and its orientation in the TCR-MHC complex. Science 274:209-219, 1996
32. Chitarra V, Alzari PM, Bentley GA, Bhat TN, Eiselé JL, Houdusse A, Lescar J, Souchon H, Poljak RJ: Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex. Proc Natl Acad Sci U S A 90:7711-7715, 1993
33. Jeffrey PD, Schildbach JF. Chang CY, Kussie PH, Margolies MN, Sheriff S: Structure and specificity of the anti-digoxin antibody 40-50. J Mol Biol 248:344-360, 1995
34. Ajitkumar P, Geier SS, Kesari KV, Borriello F, Nakagawa M, Bluestone JA, Saper MA, Wiley DC, Nathenson SG: Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell 54:47-56, 1988
35. Percus JK, Percus OE, Perelson AS: Predicting the size of the T-cell receptor and antibody combining region from consideration of efficient self-nonself discrimination. Proc Natl Acad Sci U S A 90:1691-1695, 1993
36. Peccoud J, Dellabona P, Allen P, Benoist C, Mathis D: Delineation of antigen contact residues on an MHC class II molecule. EMBO J 9:4215-4223, 1990
37. Jorgensen JL, Reay PA, Ehrich EW, Davis MM: Molecular components of T-cell recognition. Annu Rev Immunol 10:835-873, 1992
38. Dellabona P, Peccoud J, Kappler J, Marrack P, Benoist C, Mathis D: Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121, 1990
39. Arden B, Clark SP, Kabelitz D, Mak TW: Human T-cell receptor variable gene segment families. Immunogenetics 42:455-500, 1995
40. Struyk L, Hawes GE, Chatila MK, Breedveld FC, Kurnick JT, van den Elsen PJ: T cell receptors in rheumatoid arthritis. Arthritis Rheum 38:577-589, 1995
41. Waase I, Kayser C, Carlson PJ, Goronzy JJ, Weyand CM: Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum 39:904-913, 1996
42. Wucherpfennig KW, Hafler DA: A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. Ann N Y Acad Sci 756:241-258, 1995
43. Li Y, Sun GR, Tumang JR, Crow MK, Friedman SM: CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells: evidence for an antigen-driven response. J Clin Invest 94:2525-2531, 1994
44. Wucherpfennig KW, Hafler DA, Strominger JL: Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes. Proc Natl Acad Sci U S A 92:8896-8900, 1995
45. Hong SC, Chelouche A, Lin RH, Shaywitz D, Braunstein NS, Glimcher L, Janeway CA Jr: An MHC interaction site maps to the amino-terminal half of the T cell receptor alpha chain variable domain. Cell 69:999-1009, 1992
46. Jorgensen JL, Esser U, Fazekas de St. Groth B, Reay PA, Davis MM: Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224-230, 1992
47. Ghosh P, Amaya M, Mellins E, Wiley DC: The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457-462, 1995
48. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc Natl Acad Sci U S A 93:734-738, 1996
49. Nalefski EA, Kasibhatla S, Rao A: Functional analysis of the antigen binding site on the T cell receptor alpha chain. J Exp Med 175:1553-1563, 1992
50. Lone YC, Bellio M, Prochnicka-Chalufour A, Ojcius DM, Boissel N, Ottenhoff TH, Klausner RD, Abastado JP, Kourilsky P: Role of the CDR1 region of the TCR beta chain in the binding to purified MHC-peptide complex. Int Immunol 6:1561-1565, 1994
51. Brawley JV, Concannon P: Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues. J Exp Med 183:2043-2051, 1996
52. Reay PA, Kantor RM, Davis MM: Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J Immunol 152:3946-3957, 1994
53. Danska JS, Livingstone AM, Paragas V, Ishihara T, Fathman CG: The presumptive CDR3 regions of both T cell receptor α and β chains determine T cell specificity for myoglobin peptides. J Exp Med 172:27-33, 1990
54. Geluk A, Fu XT, van Meijgaarden KE, Jansen YY, de Vries RR, Karr RW, Ottenhoff TH: T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain. Eur J Immunol 24:3241-3244, 1994
55. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F: Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181:1847-1855, 1995
56. Krieger JI, Karr RW, Grey HM, Yu W-Y, O'Sullivan D, Batovsky L, Zheng Z-L, Colon SM, Gaeta FCA, Sidney J, Albertson M, del Guercio M-F, Chesnut RW, Sette A: Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J Immunol 146:2331-2340, 1991
57. Yamanaka K, Kwok WW, Mickelson EM, Masewicz S, Nepom GT: T-cell receptor V beta selectivity in T-cell clones alloreactive to HLA-Dw14. Hum Immunol 33:57-64, 1992
58. Howell MD, Diveley JP, Lundeen KA, Esty A, Winters ST, Carlo DJ, Brostoff SW: Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci U S A 88:10921-10925, 1991
59. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL: Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253:325-329, 1991
60. Kovats S, Nepom GT, Coleman M, Nepom B, Kwok WW, Blum JS: Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J Clin Invest 96:217-223, 1995
61. Fields BA, Malchiodi EL, Li HM, Ysern X, Stauffacher CV, Schlievert PM, Karjalainen K, Mariuzza RA: Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 384:188-192, 1996